Learn about convertible securities, their types, features, and benefits, and understand conversion processes of bonds and ...

The Company intends to grant the underwriters of the offering a 30-day option to purchase up to an additional $60,000,000 aggregate principal amount of Convertible Notes, solely to cover ...

Convertible bonds and convertible stocks are a tool that public companies often use for large financings to avoid disturbing their equity cap tables. Warren Buffett’s Berkshire Hathaway has been a big ...

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced its intention to offer, subject to market and other conditions, $2 billion aggregate principal amount of ...

HOUSTON--(BUSINESS WIRE)--CenterPoint Energy, Inc. (NYSE: CNP) or “CenterPoint” today announced the pricing of its offering of $900 million aggregate principal amount of its 3.00% Convertible Senior ...

Gossamer Bio, Inc. (NASDAQ: GOSS) (the "Company" or "Gossamer"), a biopharmaceutical company focused on the development and ...

HOUSTON--(BUSINESS WIRE)--PROS Holdings, Inc. (NYSE: PRO) (the “Company”) today announced the pricing of its previously announced private offering of $150.0 million aggregate principal amount of ...

Bitcoin treasury company Strategy announced on Friday that it will repurchase $1.5 billion in 0% convertible notes, due in 2029, retiring about half of the 2029 convertible note tranche’s total ...

SAN JOSE, Calif.--(BUSINESS WIRE)-- Super Micro Computer, Inc. (NASDAQ: SMCI) (“Supermicro” or the “Company”), a Total IT Solution Manufacturer for AI, Cloud, Storage, and 5G/Edge, today announced the ...

Despite starting the quarter on a positive note, risk assets closed weaker, as post-U.S. election optimism waned and tariff headlines took center stage. U.S. equities closed the quarter lower by 4.3%, ...

Franklin Fund saw a slight 1Q26 decline as tech sector cooling offset robust convertible issuance trends. Read the full ...

Gossamer Bio, Inc. (NASDAQ: GOSS) (the "Company" or "Gossamer"), a biopharmaceutical company focused on the development and ...